Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02460276
Brief Title: A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma (PHILEMON)

First Submitted : May 26, 2015
First Submitted that Met QC Criteria : May 28, 2015
First Posted : June 2, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 22, 2020
Last Update Posted : April 24, 2020